The decreased expression of CEACAM1 (Supplemental Fig. 2d) and EPHA2 (Supplemental Fig. 2e) was found to be associated with several cancers, but ITGB5 reduction in expression was associated with acute myeloid leukemia (LAML) only (Supplemental Fig. 2f). This evidence concerns the gene CEACAM1 and cancer.